# European Opportunities Trust Plc portfolio performance falls behind Benchmark

- Link: https://www.directorstalkinterviews.com/european-opportunities-trust-plc-portfolio-performance-falls-behind-benchmark/4121185972
- Published: 2025-02-07T07:46:42+00:00
- Author: Amilia Stone

**European Opportunities Trust Plc** (LON:EOT) has announced its Half Yearly Financial
Report for the six months to 30 November 2024.

**Financial Highlights**

·     Net asset value total return (with dividends reinvested) of (8.4)% and share
price total return of (10.6)% for the period, compared with a total return of (3.3)%
for the Company’s Benchmark, the MSCI Europe Total Return Index in GBP.

·    Net asset value total return (with dividends reinvested) of 988.5% since launch
on 20 November 2000 (equivalent to 10.5% compound per year), outperforming the total
return of the Benchmark of 287.3% over the same period (equivalent to 5.8% compound
per year).

·    Continued buy back activity during the period, with a total of 2.9 million 
shares repurchased at a cost of £24.5 million since the beginning of the financial
year (as at 31 January). 

·     The Company’s discount to NAV was 12.3% at the period end. The Board proposes
to make an additional tender offer for up to 25% of the issued share capital of 
the Company, which is expected to take place in Q2 2025.

**Summary of returns for the six months to 30 November 2024**

| ** ** | **30 November****2024** | **31 May****2024** | **  ****% change** | 
| Net asset value per share (pence) | 921.66 | 1008.48 | (8.6) | 
| Net asset value total return (with dividends reinvested)^(*) |  |  | (8.4) | 
| Middle market share price (pence) | 808.00 | 906.00 | (10.8) | 
| Share price total return (with dividends reinvested)* |  |  | (10.6) | 
| MSCI Europe Total Return Index in GBP (Benchmark) |  |  | (3.3) | 
| Discount to net asset value at period end (%) | (12.3) | (10.2) |  |

* _A dividend of 2.0p was paid on 2 November 2024._

Source: MSCI & Devon Equity Management Limited. Past performance is no guide to 
the future.

**Long term track record**

| ** **** **** **** ****To 30 November 2024** | ** **** **** ****3 years****%** | ** **** **** ****5 years****%** | ** **** **** ****10 years****%** | ** ****Since launch on 20.11.2000****%** | **Annualised return since launch****%** | 
| Net asset value total return (with dividends reinvested) | 0.1 | 10.6 | 108.3 | 988.5 | 10.5 | 
| Share price total return (with dividends reinvested) | (0.8) | (0.8) | 84.8 | 804.9 | 9.6 | 
| MSCI Europe Total Return Index in GBP (Benchmark) | 19.7 | 41.8 | 107.9 | 287.3 | 5.8 |

_Source: MSCI & Devon Equity Management Limited. Past performance is no guide to
the future._

**Chair’s Statement**

I present the Company’s interim results covering the six months ended 30 November
2024.

**Performance overview**

During the period under review the total return on the net asset value was -8.4%(
with the annual dividend reinvested), which compares with a total return of -3.3%
from our Benchmark, the MSCI Europe Total Return Index in GBP. The total return 
on the market price of the Company’s shares was -10.6% (again, with the annual dividend
reinvested).

Since launch, the Company has generated an annualised NAV total return of 10.5% 
and an annualised share price total return of 9.6% as at 30 November 2024, compared
with 5.8% annualised for the Benchmark over the same period. However the results
and our returns in recent years are clearly disappointing.

Our Investment Manager pursues a differentiated, high conviction approach to investment
and we, as a Board, along with the team at Devon are fully committed to returning
the Company to its former ranking at the head of its peer group.

**Discount Management**

The discount to NAV on the Company’s shares was 12.3% on 30 November 2024, widening
from 10.2% on 31 May 2024, the Company’s financial year end. This compares with 
the 10.7% weighted-average discount on 30 November 2024 for the Company’s peers 
in the AIC Europe sector.

The Board has an active discount management policy, the primary purpose of which
is to reduce discount volatility. It seeks to maintain the discount in single digits
in normal market conditions through an active share buy back programme. Reflecting
this, a total of 2.9 million shares have been repurchased into treasury at a cost
of £24.5 million since the beginning of the financial year (as at 31 January 2025).

This has followed on from the implementation in January 2024 of a tender offer at
close to NAV for up to 25% of the shares in issue, which was fully subscribed. The
Board also announced at that time proposals for a further performance-related tender
offer for up to 25% of the shares in issue in the event that the Company’s net asset
value total return does not equal or exceed the Benchmark total return over the 
three-year period ending on 31 May 2026. The Company is also committed to putting
a continuation vote to shareholders at the 2026 AGM in accordance with its three-
yearly continuation vote cycle.

**Proposal for Additional Tender Offer**

While the Board continues to place confidence in the people, process and philosophy
of our Investment Manager, we are mindful of the persistence of the double-digit
discount and the recently disappointing performance of the Company’s portfolio. 
Accordingly, to supplement the Board’s continuing use of share buy backs and to 
its existing commitments described above, the Board proposes to make an additional
tender offer in 2025 for up to 25% of the issued share capital of the Company (the‘**
Tender Offer**‘).

The Tender Offer, expected to take place in Q2 2025, will be priced at a two per
cent. discount to the prevailing net asset value at the time of repurchase, less
the costs of implementing the Tender Offer. The Tender Offer will be subject to 
shareholder approval. A circular setting out the full details of the Tender Offer
and convening the necessary general meeting will be sent to shareholders in due 
course.

**Gearing**

As of 30 November 2024, the net gearing level on our portfolio was 11.5%, a notable
increase from 1.3% on 30 November 2023. We believe that strategic borrowing can 
play an important role in enhancing long-term returns and the current level of gearing
reflects our Investment Manager’s confidence in the outlook for our portfolio. The
Company has a £85 million secured multi-currency revolving credit facility with 
The Bank of Nova Scotia, London Branch.

**Shareholder engagement**

Engagement with our shareholders is a top priority. Over the past year we have interacted
with a majority of our share register, gaining valuable insights and feedback. We
remain committed to maintaining an open dialogue with all shareholders.

**Outlook**

Despite the current challenges, we and our Investment Manager continue to note the
superior characteristics and earnings growth of our portfolio and we believe the
Company is well-positioned to deliver attractive returns for our shareholders.

I would like to express my sincere thanks to all of our shareholders and stakeholders
for their continuing support.

**Matthew Dobbs**

Chair, European Opportunities Trust

6 February 2025

**Investment Manager’s Review**

Our positioning of the portfolio during the period under review recognises the broad
spectrum of challenges in Europe: slow growth, high costs and political turmoil 
and is well positioned for a range of economic eventualities. It also recognises
the tremendous growth opportunities available to be exploited by the best companies.
Our investee companies are typically high margin, intellectual property and technology
based (as distinct from energy or capital-intensive) service businesses that have
significant revenues in the US and elsewhere in the world,

There are identifiable themes in our portfolio: Artificial Intelligence (AI) winners,
technology leaders, electrification and disruptive business models.

As regards AI, we deem **RELX**, **Experian** and **Deutsche Boerse** to be beneficiaries,
irrespective of which AI technologies prevail. In all cases, owning the data and
flow of business is key. These companies enhance the quality of existing services
with the use of AI in a way that competitors which lack the data and flows cannot.
Our technology leaders span healthcare, with companies like **Camurus**, payments
companies like **Edenred**, and information technology companies like **Dassault
Systèmes**. As for electrification, we invest in **Prysmian**, which is the world’s
leading cable company and an obvious beneficiary of the electrification trend, and**
GTT** which is a prime winner from the increasing use of liquified natural gas, 
which is needed to satisfy growing electricity demand, itself driven by demand from
energy intensive data centres and AI. **Ryanair, Wise**, and **Genus** are also 
strong examples of disruptive business models in their respective sectors. **Novo
Nordisk**, our biggest holding, is also a disruptor, expanding into the prediabetic
space, and blazing a trail with new therapies to tackle obesity.

**Performance**

Notwithstanding our strategy to avoid the challenges of Europe and tap into the 
faster growing global opportunities, our portfolio’s performance fell behind the
Benchmark during the period under review. We discuss the key contributors and detractors
to this result below.

The following tables detail which stock positions in the Company’s portfolio had
the greatest impact on performance during the six months under review, both positive
and negative. The impact is the result of price performance of each stock over the
period, calculated on a transaction basis and including the impact of foreign currency:

**Positive Contributors**

| **Security** | **Portfolio weight ****at 30.11.2024****%** | **Benchmark weight  at 30.11.2024****%** | **6 month price****performance****%** | **6 month contribution****to portfolio return****%** | 
| Deutsche Boerse | 7.4 | 0.4 | 18.0 | 1.1 | 
| RELX | 7.7 | 0.8 | 9.0 | 0.6 | 
| Experian | 8.1 | 0.4 | 4.8 | 0.3 | 
| Gaztransport & Technigaz (GTT) | 3.9 | 0.0 | 2.3 | 0.1 | 
| Grenke* | 0.0 | 0.0 | (12.4) | 0.1 |

_^(*)__Sold during the period under review._

**Negative Contributors**

| **Security** | **Portfolio weight ****at 30.11.2024****%** | **Benchmark weight  at 30.11.2024****%** | **6 month price****performance****%** | **6 month contribution****to portfolio return****%** | 
| Novo Nordisk | 11.4 | 3.2 | (20.1) | (2.6) | 
| Edenred | 4.7 | 0.1 | (27.7) | (1.4) | 
| Dassault Systèmes | 6.9 | 0.2 | (14.2) | (1.0) | 
| Infineon Technologies | 4.2 | 0.4 | (18.5) | (0.9) | 
| Worldline | 1.2 | – | (47.7) | (0.6) |

The biggest positive contributor to our performance in the period under review was**
Deutsche Boerse**. The combination of leading technology capabilities, the increase
in exchange traded financial instruments and volatile energy and interest rates,
has driven the strong performance.

The next biggest contributors to our performance were **RELX** and **Experian**.
Both companies have strong proprietary data assets and have improved their offers
with the use of AI. RELX’s legal information business is a clear beneficiary in 
this respect. Indeed, the company raised its growth expectations on the back of 
AI. Experian’s core credit and analytics businesses have, too, leveraged AI to buoy
their offer. Whereas AI can be a disruption, we believe that our companies, where
relevant, gain from the use of this technology both in improving their internal 
operations and in improving the quality of their offerings.

**GTT** also performed well. It provides services to Liquified Natural Gas (LNG)
carriers. As a ‘transition’ fuel, LNG is an important element in the move to more
renewables in the energy mix.

**Detractors**

Whereas we believe the direction of politics in America is generally favourable 
for our companies, this is not necessarily the case for a couple of our holdings,
notably **Novo Nordisk**, our biggest holding, and **Genus**. Both detracted from
our performance in the period under review. The nomination of Robert F Kennedy Jr
to be the next US health secretary has alarmed investors. The nominee is deemed 
to have eccentric views which could disturb current practices in healthcare and,
in the case of Genus, animal husbandry.

The share price of **Edenred**, which offers specific-purpose payment solutions,
fell sharply. Notwithstanding the record of excellent results, investors worried
that politicians in France and Italy will seek to restrict returns through new regulations.
We recognise these regulatory threats. However, we believe that Edenred can operate
successfully even as regulations change.

Another detractor was **Dassault Systèmes**. The company has an excellent long-term
record. However, the shares performed badly over the last six months as the rate
of growth slowed. The main explanation is that European car manufacturers are grappling
with high costs, especially the costs of producing electrical vehicles, and weak
demand for those same electric vehicles. Their competitive position versus the Asian
players has deteriorated. Nevertheless, we remain confident that Dassault Systèmes
is an excellent company which will again capitalise on its strong technology platforms.

Even if individual stocks explain much, we also acknowledge the impact of our ‘style
bias’. The best performing sector in the index was Financials, notably the mainstream
banks, a sector to which we have never had significant exposure. Our rationale is
that we find better long-term value from innovative, world-leading companies in 
other sectors. However, in recent times the European-based banks have delivered 
better returns thanks to high-interest rate spreads, low loan losses and regulatory
protection which keeps out new entrants. Central banks’ money printing policies (‘
quantitative easing’) has had the effect of extending the normal business cycle,
supporting the banks’ asset quality. In due course, we are confident that the cycle
will turn down, vindicating our strategy.

Our strategy has also suffered from outflows from European equities. Private sector
savings have been squeezed by higher taxes, levied to help straitened public finances.
In addition, global asset allocators have avoided Europe, disproportionately hurting
big (as distinct from mega-sized) and mid-sized stocks, parts of the market to which
our portfolio has a greater than average exposure.

**Portfolio activity**

Portfolio turnover in the six months was 22.7% annualised (defined as purchases 
as a percentage of net assets). Sales in the period totalled £76.5m, almost half
of which was the sale of **Darktrace**, following an agreed offer for the company
by a private equity firm. The next biggest sale was that of **Soitec**, as better
opportunities were found elsewhere. The silicon carbide ‘story’ Soitec has stalled
in line with the slowing growth in sales of Electric Vehicles (EVs). We also exited
the position in **Grenke**. Having started selling on the back of good results earlier
in the year as asset quality deteriorated, we accelerated selling. The lightening
of holdings in **Novo Nordisk** and **RELX** was because of the size of the weightings,
rather than any concern about the quality of the respective businesses.

Significant new investments included **Universal Music Group** (UMG), the world’s
leading music company. It is the owner of a huge catalogue of recorded music. Digital
technology allows UMG to develop new services, platforms and business models and
thereby better monetise their catalogue. We also established positions in **BE Semiconductor
Industries** (Besi) and **Yubico**. Besi is a Dutch technology company, a world 
leader in packaging processes and hybrid bonding for the semi- conductor industry.
Swedish-listed Yubico, is a world leader in multi-factor authentication, a hardware
solution widely regarded as being the best way to foil cyber-attacks. Other smaller
purchases included the French company, **Exosens**, which is the world leader in
the manufacture of image intensifier tubes, the key component of night vision goggles.
Finally, we bought shares in **Wise**, a London based global payments technology
company.

**Outlook**

We believe that the European Opportunities Trust portfolio is better value than 
at any time since 2017. Our earnings forecasts for the portfolio companies are markedly
higher than those projected for the wider market. Yet the valuation premium on our
portfolio is modest. We project that our portfolio will grow earnings at 9.9% and
20.7% in 2025 and 2026 respectively (as at 31 January 2025). The current year valuation
premium for this earnings growth is low by historic standards. Moreover, we expect
earnings momentum for our companies to continue in 2027.

It is worth noting that the reduction in the valuation premium of the portfolio 
relative to the Benchmark since 2022 has been achieved without compromising our 
investment approach. Typically, our companies also have less debt than most European
listed companies, which we regard as prudent. The portfolio also has higher returns
on invested capital than the Benchmark.

At a macro level, slower economic growth in Europe will stymie the banks’ earnings.
Our strategy is to identify ‘winners through the cycle’, a strategy that has been
thwarted somewhat by the huge money printing programmes of the COVID era. The extended
business cycle will turn down at which point our companies’ earnings resilience 
will be clear. Typically, our investee companies have high recurrent revenues and
benefit from exposure to faster growing economies like the US.

Despite the direction of fund flows and Europe’s intractable problems, within this
portfolio we do see numerous potential catalysts from our companies this year which
would drive share prices. Although December 2024 saw disappointing phase three trial
results for Novo Nordisk’s next generation drug Cagrisema, the company has a bright
future as a global leader in treating diabetes and obesity. Our healthcare, technology
and payments companies should all make good progress. We remain confident that our
strategy of picking companies that compete and succeed on the world stage will be
vindicated.

**Alexander Darwall**

CIO, Devon Equity Management Limited

6 February 2025

Share on:
